z-logo
open-access-imgOpen Access
Topical gentamicin 0.1% promotes collagen 7 expression in recessive dystrophic epidermolysis bullosa
Author(s) -
Rahul Mahajan,
Seema Manjunath,
Manoj Gopal Madakshira,
Dipankar De,
Sabia Handa,
Debajyoti Chatterjee,
Bishan Das Radotra
Publication year - 2022
Publication title -
indian dermatology online journal
Language(s) - Uncategorized
Resource type - Journals
eISSN - 2249-5673
pISSN - 2229-5178
DOI - 10.4103/idoj.idoj_554_21
Subject(s) - medicine , gentamicin , epidermolysis bullosa , dermatology , cohort , biopsy , skin biopsy , adverse effect , surgery , antibiotics , genetics , biology
Currently, there is no cure for epidermolysis bullosa (EB) but few studies have explored the role of aminoglycosides in promoting collagen 7 expression in recessive dystrophic EB (RDEB).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here